Anterior Approach Levator Plication for Congenital Ptosis, With or Without Scraping of the Levator Muscle Surface
NCT07924228, Not applicable, Completed, Zagazig University
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Anterior Approach Levator Plication for Congenital Ptosis, With or Without Scraping of the Levator Muscle Surface | ClinicalTrials.gov |
| NCT number | NCT07924228 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 50 participants, actual | ClinicalTrials.gov |
| Lead sponsor | Zagazig University | ClinicalTrials.gov |
| Conditions | Ptosis, Eyelid | ClinicalTrials.gov |
| Interventions | Levator resection with levator muscle scraping, Levator resection without scraping | ClinicalTrials.gov |
| First posted | 2026-11-09 | ClinicalTrials.gov |
| Last updated | 2026-11-09 | ClinicalTrials.gov |
Registered outcomes 4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Change in Marginal Reflex Distance 1 (MRD1) | Preoperative baseline, and at 1 week, 4 weeks, 12 weeks, and 24 weeks postoperatively. Primary endpoint at 24 weeks. | MRD1 measured in millimeters using standard ruler with patient in primary gaze, fixating at distant light source. Measured as distance from central corneal light reflex to upper eyelid margin. Measured preoperatively and postoperatively. Improvement calculated as postoperative MRD1 minus preoperative MRD1. Measured by blinded outcomes assessor. | ClinicalTrials.gov |
| Secondary | Levator Function | Baseline and 24 weeks postoperatively | Levator function measured in mm as excursion of upper eyelid margin from extreme downgaze to extreme upgaze with frontalis muscle blocked by examiner's thumb. Assessed by blinded outcomes assessor | ClinicalTrials.gov |
| Secondary | Surgical Success Rate | 24 weeks postoperatively | Success defined as postoperative MRD1 between 3.5 to 4.5 mm with satisfactory lid contour and symmetry within 1 mm of contralateral normal eyelid at 24 weeks. Undercorrection defined as MRD1 less than 3.5 mm. Overcorrection defined as MRD1 greater than 5.5 mm. | ClinicalTrials.gov |
| Secondary | Postoperative Complications | From surgery up to 24 weeks postoperatively | Assessment of complications including overcorrection, undercorrection, lid contour abnormalities, eyelid asymmetry, suture granuloma, infection, hematoma, and need for reoperation. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)